Literature DB >> 29296738

JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics.

Thomas McKerrell1,2,3, Naomi Park1, Jianxiang Chi4,5, Grace Collord1, Thaidy Moreno6, Hannes Ponstingl1, Joao Dias7, Petroula Gerasimou4,5, Kiki Melanthiou8, Chrystalla Prokopiou9, Marios Antoniades8, Ignacio Varela6, Paul A Costeas4,5, George S Vassiliou1,2,3,4.   

Abstract

Entities:  

Year:  2017        PMID: 29296738      PMCID: PMC5737599          DOI: 10.1182/bloodadvances.2017007047

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


× No keyword cloud information.
  22 in total

1.  A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

Authors:  Damla Olcaydu; Ashot Harutyunyan; Roland Jäger; Tiina Berg; Bettina Gisslinger; Ingrid Pabinger; Heinz Gisslinger; Robert Kralovics
Journal:  Nat Genet       Date:  2009-03-15       Impact factor: 38.330

2.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

Authors:  Chloé James; Valérie Ugo; Jean-Pierre Le Couédic; Judith Staerk; François Delhommeau; Catherine Lacout; Loïc Garçon; Hana Raslova; Roland Berger; Annelise Bennaceur-Griscelli; Jean Luc Villeval; Stefan N Constantinescu; Nicole Casadevall; William Vainchenker
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

3.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Authors:  Ross L Levine; Martha Wadleigh; Jan Cools; Benjamin L Ebert; Gerlinde Wernig; Brian J P Huntly; Titus J Boggon; Iwona Wlodarska; Jennifer J Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C Lee; Stacey Gabriel; Thomas Mercher; Alan D'Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A Mesa; Ayalew Tefferi; James D Griffin; Michael J Eck; William R Sellers; Matthew Meyerson; Todd R Golub; Stephanie J Lee; D Gary Gilliland
Journal:  Cancer Cell       Date:  2005-04       Impact factor: 31.743

4.  JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate.

Authors:  Camilla Nielsen; Stig E Bojesen; Børge G Nordestgaard; Klaus F Kofoed; Henrik S Birgens
Journal:  Haematologica       Date:  2014-06-06       Impact factor: 9.941

5.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Authors:  E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; Soheila Swanton; George S Vassiliou; Anthony J Bench; Elaine M Boyd; Natasha Curtin; Mike A Scott; Wendy N Erber; Anthony R Green
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  A gain-of-function mutation of JAK2 in myeloproliferative disorders.

Authors:  Robert Kralovics; Francesco Passamonti; Andreas S Buser; Soon-Siong Teo; Ralph Tiedt; Jakob R Passweg; Andre Tichelli; Mario Cazzola; Radek C Skoda
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

7.  JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.

Authors:  Amy V Jones; Andrew Chase; Richard T Silver; David Oscier; Katerina Zoi; Y Lynn Wang; Holger Cario; Heike L Pahl; Andrew Collins; Andreas Reiter; Francis Grand; Nicholas C P Cross
Journal:  Nat Genet       Date:  2009-03-15       Impact factor: 38.330

8.  Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

Authors:  J Nangalia; C E Massie; E J Baxter; F L Nice; G Gundem; D C Wedge; E Avezov; J Li; K Kollmann; D G Kent; A Aziz; A L Godfrey; J Hinton; I Martincorena; P Van Loo; A V Jones; P Guglielmelli; P Tarpey; H P Harding; J D Fitzpatrick; C T Goudie; C A Ortmann; S J Loughran; K Raine; D R Jones; A P Butler; J W Teague; S O'Meara; S McLaren; M Bianchi; Y Silber; D Dimitropoulou; D Bloxham; L Mudie; M Maddison; B Robinson; C Keohane; C Maclean; K Hill; K Orchard; S Tauro; M-Q Du; M Greaves; D Bowen; B J P Huntly; C N Harrison; N C P Cross; D Ron; A M Vannucchi; E Papaemmanuil; P J Campbell; A R Green
Journal:  N Engl J Med       Date:  2013-12-10       Impact factor: 91.245

9.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

10.  Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture.

Authors:  N Conte; I Varela; C Grove; N Manes; K Yusa; T Moreno; A Segonds-Pichon; A Bench; E Gudgin; B Herman; N Bolli; P Ellis; D Haddad; P Costeas; R Rad; M Scott; B Huntly; A Bradley; G S Vassiliou
Journal:  Leukemia       Date:  2013-04-18       Impact factor: 11.528

View more
  14 in total

Review 1.  Germline risk of clonal haematopoiesis.

Authors:  Alexander J Silver; Alexander G Bick; Michael R Savona
Journal:  Nat Rev Genet       Date:  2021-05-13       Impact factor: 53.242

2.  Polycythemia vera emerging eighteen years after acute myeloid leukemia diagnosis.

Authors:  Stephen E Langabeer; Derick W O'Flynn; Mary R Cahill
Journal:  Blood Res       Date:  2021-06-30

3.  Concordance for clonal hematopoiesis is limited in elderly twins.

Authors:  Margarete A Fabre; Thomas McKerrell; Maximillian Zwiebel; M S Vijayabaskar; Naomi Park; Philippa M Wells; Roland Rad; Panagiotis Deloukas; Kerrin Small; Claire J Steves; George S Vassiliou
Journal:  Blood       Date:  2020-01-23       Impact factor: 25.476

4.  Life histories of myeloproliferative neoplasms inferred from phylogenies.

Authors:  Nicholas Williams; Joe Lee; Emily Mitchell; Luiza Moore; E Joanna Baxter; James Hewinson; Kevin J Dawson; Andrew Menzies; Anna L Godfrey; Anthony R Green; Peter J Campbell; Jyoti Nangalia
Journal:  Nature       Date:  2022-01-20       Impact factor: 69.504

5.  Protracted Clonal Trajectory of a JAK2 V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid Leukemia.

Authors:  Stephen E Langabeer; Karl Haslam; Maria Anne Smyth; John Quinn; Philip T Murphy
Journal:  Case Rep Hematol       Date:  2018-05-09

6.  JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis.

Authors:  Michael Y Choi; Shumei Kato; Huan-You Wang; Jonathan H Lin; Richard B Lanman; Razelle Kurzrock
Journal:  Cancer Biol Ther       Date:  2018-08-03       Impact factor: 4.742

Review 7.  Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation.

Authors:  Florian Perner; Caroline Perner; Thomas Ernst; Florian H Heidel
Journal:  Cells       Date:  2019-08-08       Impact factor: 6.600

8.  JAK2 V617F -Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure.

Authors:  Soichi Sano; Ying Wang; Yoshimitsu Yura; Miho Sano; Kosei Oshima; Yue Yang; Yasufumi Katanasaka; Kyung-Duk Min; Shinobu Matsuura; Katya Ravid; Golam Mohi; Kenneth Walsh
Journal:  JACC Basic Transl Sci       Date:  2019-09-18

9.  Ultradeep targeted sequencing reveals low allele frequencies of somatic JAK2 and MPL variants in patients with abdominal vein thromboses: results of an ongoing prospective prevalence study in Mecklenburg-West Pomerania.

Authors:  Luise Grunwald; Christina Grosse-Thie; Sina Sender; Gudrun Knuebel; Saskia Krohn; Catrin Roolf; Christian Junghanss; Larissa Henze; Hugo Murua Escobar
Journal:  Biomark Res       Date:  2020-12-14

Review 10.  Extramedullary Hematopoiesis of the Liver and Spleen.

Authors:  Diana Cenariu; Sabina Iluta; Alina-Andreea Zimta; Bobe Petrushev; Liren Qian; Noemi Dirzu; Ciprian Tomuleasa; Horia Bumbea; Florin Zaharie
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.